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Aphelandra  scabra  (Vahl)  Sm.,  Acanthaceae,  is  a shrub  widely  used  by  some  Mayan  communities  as  carmi-
native,  antidote,  and  remedy  for some  infections.  Bio-guided  isolation  of  the  methanol  extract  of leaves
led us to  the  puriﬁcation  of the  anti-giardial  metabolites  cirsimaritin  and  sorbifolin,  along  with  the  inac-
tive  metabolites  cirsimarin,  sorbifolin-6-O--glucopyranoside,  and  squalene.  Cirsimaritin  displayed  high







pared  to previous  reported  metabolites,  while  sorbifolin  showed  a  low  activity  with  an  IC50 = 75.6  M.
Additionally,  both  compounds  proved  not  to  be  cytotoxic  in an  in vitro  bioassay  against  HEK-293,  a  nor-
mal  cell  line.  This  is the  ﬁrst  investigation  on  anti-giardial  properties  of  A.  scabra  and  its  phytochemistry
as  well,  thus  the isolated  compounds  are  considered  as  new  for  the  plant  genus and  for the  species.
© 2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.
lavonoids
ntroduction
Giardiasis caused by the ﬂagellated protozoan Giardia lam-
lia (G. intestinalis,  G. duodenalis)  is the most common parasitic
isease affecting humans worldwide (Vázquez-Tsuji and Campos-
ivera, 2009). It causes an estimated 2.8 × 108 cases per year (Lane
nd Lloyd, 2002). In Mexico, the National System for Epidemio-
ogic Surveillance reported 20,599 cases in 2010 (SINAVE, 2010);
hereas Yucatan shows an incidence of 15.2% (Mantilla-Morales
t al., 2002).
Symptoms of giardiasis include abdominal cramps and pain,
nd diarrhea, which can lead to malabsorption and failure
f children to thrive (Tejman-Yarden and Eckmann, 2011). A
ariety of chemotherapeutic agents such as 5-nitroimidazole com-
ounds, quinacrine, furazolidone, paromomycin, benzimidazole
ompounds, and nitazoxanide have been used in the therapy
or giardiasis. Nevertheless, most drugs used have considerable
dverse effects and in addition Giardia seems to have a great ability
o resist these agents (Bussati et al., 2009). Thus, the discovery of
ew, effective, and safe antigiardial agents is imperative from other
ources (Peraza-Sanchez et al., 2005).
Aphelandra scabra (Vahl.) Sm., Acanthaceae, a plant distributed
n the southeast of Mexico, Central and South America (Flora digital:
∗ Corresponding author.
E-mail: speraza@cicy.mx (S.R. Peraza-Sánchez).
http://dx.doi.org/10.1016/j.bjp.2015.04.004
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier EditoraPeninsula de Yucatan, 2010), is used in Mayan Q’ eqchi’ traditional
medicine to treat several conditions, including circulatory, mental,
and nervous system disorders, poisoning, and infections (Treyvaud
et al., 2005). In Honduras, a beverage made from mashed roots
and/or leaves soaked in cool water is used as an antiﬂatulent (Lentz,
1993). Antimicrobial and leishmanicidal activities of the methanol
extract from this plant have been reported (Peraza-Sánchez et al.,
2007; Meurer-Grimes et al., 1996), therefore, a study was con-
ducted in order to investigate the anti-giardial properties of this
species.
In this study, we report the isolation of four known ﬂavonoids
and a triterpene from the leaves of A. scabra and their anti-giardial
activity. It is worth mentioning that this is the ﬁrst phytochemical
investigation of A. scabra.
Materials and methods
General experimental procedures
Melting points were determined using a Melt-Temp II Appara-
tus (Laboratory Devices, USA). GC–MS data were determined on an
Agilent 6890N gas chromatograph coupled to a 5975B mass spec-
trometer. 1H NMR  (400 MHz) and 13C NMR  (100 MHz) data were
obtained on a Bruker Avance 400 spectrometer. Chemical shifts
were referred to TMS  (ı 0). IR spectra were recorded as KBr pellets
on a Nicolet Protegé 460. UV spectra were performed on a Genesys
10 UV ThermoSpectronic. Vacuum liquid chromatography (VLC)
 Ltda. All rights reserved.
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Table 1
Yield and anti-giardial activity of methanol extract and fractions of A. scabra.
Sample Yield [g (%)] IC50 (g/ml)
MeOH extract (ASH-1) 435.0 (14.41)a 11.74 ± 1.12c
Hx fraction (ASH-2a) 21.5 (4.94)b NAd
DCM fraction (ASH-2b) 4.3 (0.99)b 2.19 ± 0.67
EtOAc fraction (ASH-2c) 4.6 (1.05)b NA
Aqueous fraction (ASH-2d) 62.0 (14.25)b NA
Metronidazole 0.2 ± 0.02













































(Yield based on weight of methanol extract.
c Standard deviation.
d Not active.
as performed under vacuum using silica gel 60 GF254 (200–400
esh, Sigma–Aldrich). Thin layer chromatography (TLC) was  car-
ied out on silica gel F254 (Merck) and visualized under UV light
nd by spraying with phosphomolybdic acid reagent followed by
eating.
lant material
Aphelandra scabra (Vahl.) Sm., Acanthaceae, leaves were col-
ected from its natural habitat, in the locality of Piste, Yucatan
Mexico), in July 2010. A voucher specimen (PSima-3019), identi-
ed by a qualiﬁed taxonomist, was deposited at CICY’s U Najil Tikin
iu herbarium.
xtraction and isolation
Ground dried leaves (3018 g) were extracted with methanol for
4 h and then solvent was evaporated under vacuum. This process
as repeated once again. The methanol extract (ASH-1, 435 g) was
artitioned with hexane (Hx), dichloromethane (DCM) and ethyl
cetate (EtOAc), for three times each one. Solvent was evaporated
nder vacuum. Resulting fractions including aqueous phase (ASH-
a–ASH-2d) were placed in separate vials and weighted (Table 1).
he hexane fraction ASH-2a (5 g) was further fractionated in a
acuum liquid chromatography (VLC) column using mixtures of
x, acetone (An), EtOAc, and MeOH to obtain ﬁve fractions (ASH-
a–ASH-3e). Fraction ASH-3a was puriﬁed by a chromatographic
olumn (CC) using Hx to afford squalene (1, 22.5 mg). The DCM frac-
ion ASH-2b (4 g) was further fractionated by VLC using mixtures of
x, Hx/An, and An/MeOH to obtain eleven fractions (ASH-4a–ASH-
k). Crystallization with MeOH of fractions ASH-4d–ASH-4i yielded
irsimaritin (2, 465.6 mg). The EtOAc fraction ASH-2c (3.8 g) was
ractionated by VLC using mixtures of same solvents used to
ractionate DCM extract yielding nine fractions (ASH-6a–ASH-6i).
rystallization with MeOH of fraction ASH-6 h gave cirsimarin (3,
5.1 mg); meanwhile, crystallization with MeOH of fraction ASH-6c
ielded sorbifolin (4, 11.3 mg). Fraction ASH-6i was puriﬁed by VLC
sing mixtures of Hx/DCM, DCM/An, and DCM/MeOH to obtain ten
ractions (ASH-23a–ASH-23j). The MeOH crystallization of fraction
SH-23f led to the isolation of sorbifolin-6-O--glucopyranoside
5, 5.3 mg). Purities of the isolated ﬂavonoids were veriﬁed through
LC and determination of their melting points, while purity of com-
ound 1 was determined by means of CG-EM.
Squalene (1): yellow oil; GC–MS Rt = 13.168 min, m/z (%): 410
[M+H]+) (1), 341 (3), 273 (1), 137 (14), 95 (18), 41 (37), 69 (100,
ase peak).
Cirsimaritin (2): yellow needles; Rf (Hx/An; 2:1, 2×): 0.37, m.p.
53.8–256.2 ◦C. UV (An:H2O; 99:1) max nm (log ε): 209 (3.21), 330
3.39). IR max (KBr) cm−1: 3283, 1655, 1600, 1570, 1465, 1445,
356, 1037, 853. 1H NMR  (400 MHz, DMSO-d6) ı 3.72 (3H, s, 6-
CH3), 3.90 (3H, s, 7-OCH3), 6.81 (1H, s, H-3), 6.87 (1H, s, H-8), 6.92
2H, d, J = 8.8 Hz, H-3′, H-5′), 7.93 (2H, d, J = 8.8 Hz, H-2′, H-6′), 12.91 de Farmacognosia 25 (2015) 233–237
(1H, s, 5-OH). 13C NMR  (100 MHz, DMSO-d6) ı 55.7 (6-OCH3), 59.7
(7-OCH3), 101.4 (C-8), 103.0 (C-3), 104.6 (C-10), 114.7 (C-3′), 116.3
(C-5′), 120.7 (C-1′), 127.3 (C-2′), 128.9 (C-6′), 131.4 (C-6), 151.6 (C-
9), 152.2 (C-5), 158.1 (C-7), 160.8 (C-4′), 163.6 (C-2), 181.7 (C-4).
Cirsimarin (3): white amorphous powder; Rf (CH2Cl2/MeOH;
4.5:0.5, 3×): 0.50, m.p. 175.8–176.3 ◦C. UV (MeOH) max nm (log ε):
213 (4.89), 277 (4.72), 323 (4.75). IR max (KBr) cm−1: 3350, 1660,
1600, 1565, 1460, 1440, 1356, 1047, 833. 1H NMR  (400 MHz, DMSO-
d6) ı 3.20–3.71 (6H, sugar H), 3.74 (3H, s, 6-OCH3), 3.93 (3H, s,
7-OCH3), 4.65 (1H, s, 6′′-OH), 5.05 (1H, d, J = 7.1 Hz, H-1′′), 5.12 (1H,
s, 4′′-OH), 5.20 (1H, s, 3′′-OH), 5.45 (1H, s, 2′′-OH), 6.97 (1H, s, H-
3), 6.98 (1H, s, H-8), 7.20 (2H, d, J = 8.8 Hz, H-3′, H-5′), 8.08 (2H,
d, J = 8.8 Hz, H-2′, H-6′), 12.86 (1H, s, 5-OH). 13C NMR  (100 MHz,
DMSO-d6) ı 55.6 (7-OCH3), 60.1 (6-OCH3), 60.7 (C-6′′), 69.7 (C-4′′),
73.2 (C-2′′), 76.6 (C-5′′), 77.2 (C-3′′), 91.7 (C-8), 99.8 (C-1′′), 103.7
(C-3), 105.2 (C-10), 116.6 (C-3′, C-5′), 123.9 (C-1′), 128.3 (C-2′, C-
6′), 131.9 (C-6), 152.1 (C-5), 152.7 (C-9), 158.8 (C-7), 160.4 (C-4′),
163.4 (C-2), 182.4 (C-4).
Sorbifolin (4): yellow solid; Rf (Hx/An; 3:2, 2×): 0.52, m.p. 235 ◦C
(d). UV (EtOH) max nm (log ε): 206 (4.55), 281 (4.24), 338 (4.38).
IR max (KBr) cm−1: 3173, 1665, 1570, 1500, 1455, 1361, 1027, 828.
1H NMR  (400 MHz, DMSO-d6) ı 3.91 (3H, s, 7-OCH3), 6.81 (1H, s,
H-3), 6.91 (1H, s, H-8), 6.93 (2H, d, J = 8.8 Hz, H-3′, H-5′), 7.95 (2H,
d, H-2′, H-6′), 8.74 (6-OH), 10.39 (4′-OH), 12.64 (5-OH). 13C NMR
(100 MHz, DMSO-d6) ı 56.3 (7-OCH3), 91.2 (C-8), 102.5 (C-3), 105.0
(C-10), 116.0 (C-3′, C-5′), 121.4 (C-1), 128.4 (C-2′, C-6′), 129.9 (C-6),
146.2 (C-5), 149.7 (C-9), 154.4 (C-7), 161.2 (C-4′), 163.8 (C-2), 182.3
(C-4).
Sorbifolin-6-O--glucopyranoside (5): white amorphous pow-
der; Rf (CH2Cl2/MeOH; 4:1): 0.62, UV (An:H2O; 62.5:1) max nm
(log ε): 209 (3.16), 329 (3.04). IR max (KBr) cm−1: 3500–3100, 1660,
1605, 1565, 1500, 1460, 1356, 1047. 1H NMR  (400 MHz, DMSO-d6)
ı 3.58 (1H, dd, J = 4.0, 11.1 Hz, 6b′′-OH), 3.90 (3H, s, 7-OCH3), 4.12
(1H, dd, J = 5.0, 10.4 Hz, 6a′′-OH), 4.32 (1H, t, J = 5.5 Hz, 5′′-OH), 4.94
(1H, d, J = 5.2 Hz, H-1′′), 5.03 (1H, d, J = 4.8 Hz, 4′′-OH), 5.05 (1H, s,
3′′-OH), 5.17 (1H, d, J = 3.3 Hz, 2′′-OH), 6.86 (1H, s, H-3), 6.92 (2H,
d, J = 8.7 Hz, H-3′, H-5′), 6.93 (1H, s, H-8), 7.97 (2H, d, J = 8.7 Hz, H-
2′, H-6′), 10.43 (1H, brs, 4′-OH), 13.06 (1H, brs, 5-OH). 13C NMR
(100 MHz, DMSO-d6) ı 56.6 (7-OCH3), 60.9 (C-6′′), 69.9 (C-4′′), 74.2
(C-2′′), 76.6 (C-5′′), 77.3 (C-3′′), 91.7 (C-8), 102.0 (C-3), 102.7 (C-1′′),
104.9 (C-10), 116.0 (C-3′, C-5′), 121.1 (C-1), 128.1 (C-6), 128.6 (C-2′,
C-6′), 151.7 (C-5), 152.6 (C-9), 158.6 (C-7), 161.3 (C-4′), 164.0 (C-2),
182.3 (C-4).
Parasite and culture conditions
In this study, G. lamblia IMSS:0696:1 isolate, obtained from an
individual with symptomatic giardiasis, was used (Cedillo-Rivera
et al., 2003). Trophozoites were cultured in TYI-S-33 modiﬁed
medium, supplemented with 10% calf serum, and subcultured twice
a week; for the assay, trophozoites were tested in their log phase
of growth (Cedillo-Rivera et al., 1991).
Growth inhibition assay
In vitro susceptibility of G. lamblia was  determined as previously
described (Cedillo-Rivera and Mun˜oz, 1992). Stock solutions of
extracts, fractions and pure compounds were prepared with DMSO
(5 mg/ml), following serial two-fold dilutions in 1.5 ml  volumes of
culture medium in microcentrifuge tubes to afford concentrations
of 5, 10, 20, and 50 g/ml. The tubes were inoculated with G. lamblia
to achieve an inoculum of 5 × 104 trophozoites/ml. As positive con-
trol, tubes with metronidazole were similarly inoculated. Tubes of
culture medium with DMSO and the same inoculum were used as
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ere detached by chilling and 50 l of each culture tube was sub-
ultured into 1.5 ml  of fresh culture medium and incubated for 48 h
t 37 ◦C. The ﬁnal number of parasites was determined by counting
n a haemocytometer, and the percentage of trophozoites growth
nhibition was calculated by comparison with controls. The 50%
nhibitory concentration (IC50) was deﬁned as the concentration of
he extract, fraction or pure compound that inhibited growth by
0% as calculated by probit analysis using the Graphpad Prism 6.0
oftware. Each experiment was done in duplicate and was repeated
t least three times.
ytotoxic assay of active compounds
Active compounds were also tested in a cytotoxic bioassay in
rder to discard that the anti-giardial activity was due to toxic
ffects. Cytotoxicity assay was performed according to the estab-
ished method of Rahman et al. (2001), where 1.5 × 104 viable cells
rom HEK-293 cell line were seeded in a 96-well plate (Costar) and
ncubated for 24–48 h. When cells reached >80% conﬂuence, the
edium was replaced and cells were incubated with compounds
t successive concentrations (0.97, 1.95, 3.90, 7.81, 15.62, 31.25,
2.5, 125, 250, 500 g/ml) and dissolved in DMSO at a maximum
oncentration of 0.05%. After 72 h of incubation, 10 l of 3-(4,5-
imethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide solution
MTT, Sigma) solution (5 mg/ml) was added to each well and incu-
ated at 37 ◦C for 4 h. The medium was removed and the formazan,
 product generated by the activity of dehydrogenases in cells, was
issolved in acidiﬁed isopropanol (0.4 N HCl). The amount of MTT-
ormazan is directly proportional to the number of living cells and
as determined by measuring the optical density (OD) at 590 nm
sing a Bio-assay reader (BioRad, USA). Cells incubated only with
.05% of DMSO were used as a negative control. All determinations
ere performed in triplicate. The CC50 values were calculated using
he Graphpad Prism 6.0 software.
esults and discussion
The methanol extraction of the A. scabra leaves yielded 435 g of
he crude extract ASH-1 (14.41%, w/w). Liquid–liquid partition of
his extract gave fractions ASH-2a–ASH-2d (Table 1). These frac-
ions together with the extract ASH-1 were all evaluated against
. lamblia. From the tested fractions, only the ASH-1 extract and
SH-2b fraction were active with an IC50 = 11.74 and 2.19 g/ml,
espectively (Table 1) and considered high, according to the crite-
ia established by Amaral et al. (2006). To continue the bio-assay
uided study, a VLC of the ASH-2b fraction was carried to obtain
leven subfractions which were also tested against G. lamblia
Table 2). The active subfractions showed a common metabolite
able 2
nti-giardial activity of VLC subfractions of the DCM fraction of the methanol extract













Metronidazole 0.2 ± 0.02
a Not active.
b Not tested. de Farmacognosia 25 (2015) 233–237 235
when observed in TLC plates. Recrystallization of the abovemen-
tioned fractions led to the puriﬁcation of a compound as yellow
needles. Such metabolite was  identiﬁed as cirsimaritin (2) by
comparison of its spectroscopic data with those reported in the
literature (Lin et al., 2006). This metabolite has been previously
isolated from the species Cirsium rhinoceros (Yim et al., 2003),
Stizolophus balsamita (Suleimenov et al., 2008), and Helychrisum vis-
cosum (Geissman et al., 1967) belonging to the Asteraceae family;
Teucrium ramosissimum (Ben Sghaier et al., 2011), Dracocephalum
multicaule (Oganesyan, 2009), and Ocimum sanctum from Lami-
aceae (Kelm et al., 2000); Microtea debilis (Phytolaccaceae) (Bai
et al., 2011); and Ruellia tuberosa, a species of Acanthaceae, same
family as the genus Aphelandra (Lin et al., 2006). According to
the literature, this molecule possesses a wide range of biological
activities, such as antioxidant (Ben Sghaier et al., 2011), cytotoxic
against KB and GBC-SD cell lines (Lin et al., 2006; Quan et al.,
2010), antiproliferative against COLO-205 cells (Bai et al., 2011),
and antiprotozoal against Leishmania donovani, Trypanosoma brucei
rhodesiense and T. cruzi (Tasdemir et al., 2006). The phytochemical
study of ASH-2a fraction led us to obtain the triterpene squalene
(1), which was identiﬁed by comparison of its fragmentation pat-
tern with those in the NIST library provided by the GC-MS. Study of
ASH-2c fraction allowed the isolation of the ﬂavone sorbifolin (4)
and two  glycosylated ﬂavones: cirsimarin (3) and sorbifolin-6-O-ˇ-
glucopyranoside (5), which were identiﬁed by comparison of their
spectroscopic data with those reported in the literature (Fernandes
et al., 2008; Lin et al., 2006; Yim et al., 2003). Sorbifolin has been iso-
lated from the species Astragalus annularis (El-Hawiet et al., 2010)
and Pterogyne nitens from Fabaceae family (Fernandes et al., 2008);
Heterotheca subaxilaris (Morimoto et al., 2009) and Pulicaria uligi-
nosa (Eshbakova et al., 1996) from Asteraceae; and R. tuberosa from
Acanthaceae (Lin et al., 2006). Regarding its biological activities,
this ﬂavonoid has been tested in antimicrobial, antioxidant, and
myeloperoxidase bioassays, resulting in moderate to null activity
(El-Hawiet et al., 2010; Fernandes et al., 2008). Meanwhile, isolation
of cirsimarin has been reported from species such as R. tuberosa, Cir-
sium lineare, C. rhinoceros,  Teucrium arduini and M. debilis (Vukovic
et al., 2011; Bai et al., 2011; Jeong et al., 2008; Lin et al., 2006; Yim
et al., 2003). In the other hand, sorbifolin-6-O-ˇ-glucopyranoside
has been isolated from Pterogyne nitens (Fernandes et al.,
2008).
2 R1 = CH3; R 2 = H
3 R1 = CH3; R 2 = Glc
4 R1 = R2 = H






Compounds 2, 3, and 4 were tested in the anti-giardial bioas-
say and the results are described in Table 3. Among the tested
compounds, 2 displayed high activity with an IC50 = 3.8 M,
being considered as outstanding, when compared with previous
reported secondary metabolites, such as usambarensine, which
showed an IC50 = 8.99 M (Wright et al., 1994), (−)-epicatechin
with and IC50 = 5.82 M (Calzada et al., 2005), and tingenone hav-
ing an IC50 = 0.74 M (Mena-Rejon et al., 2007), while 4 showed an
IC50 = 75.6 M,  being this activity considered low.
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Table 3
Anti-giardial, cytotoxic activity and selective index (SI) of pure secondary metabo-






Cirsimaritin (2) 3.8 378.68 ± 3.44b 310
Cirsimarin (3) NAa NA –
Sorbifolin (4) 75.6 478.56 ± 6.78 21





































Aa NA: not active.
b Standard deviation.
Compound 1 showed an IC50 = 241.28 M in a previous study
Calzada, 2005); therefore, it was not tested in the present work,
hile compound 5 was puriﬁed sparingly, thus it could not be
ested against G. lamblia.
Noteworthy is the ﬁnding that both active ﬂavonoids had a typi-
al ﬂavone structure (2,3 and C-4 keto functions) and groups such
s 4′,5-OH. No activity was  observed in compound 3, where 4′-OH
s substituted by glucose, despite the fact that its aglicone 2 was  the
ost active in the present study. That tendency allows suggesting
hat inhibition is considerably reduced by the presence of the sugar,
n accordance with Calzada and Alanís (2007).
The bioactive compounds were also tested in a cytotoxic bioas-
ay in order to discard that the anti-giardial effect was due to
ytotoxicity. In this bioassay, both metabolites proved to be not
ytotoxic (Table 3). In particular, cirsimaritin showed a high SI
ndicating its elevated selectivity to G. lamblia cells. These results
re in accordance with Nijveldt et al. (2001), who  concluded that
avonoids are not toxic or less toxic to normal cells, and thus
onﬁrming the potential of these ﬂavones to be used as safe anti-
iardial agents, although more analyses are necessary to establish
f these compounds can be used in humans.
In conclusion, we suggest that cirsimaritin and sorbifolin are the
etabolites responsible for the anti-giardial activity exhibited by
he methanol extract of A. scabra leaves, being the present study the
rst report on the phytochemistry of this species, thus the isolated
ompounds are considered as new for the genus and the species.
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